Allison Frisbee, J.D., joined Kronos Bio in September 2020 as Vice President, Associate General Counsel. Prior to joining Kronos Bio, she was Senior Corporate Counsel at Jazz Pharmaceuticals where she provided strategic counsel for the development, launch and commercialization of a broad portfolio of neuroscience and oncology therapeutics such as Xyrem, Xywav, Zepzelca, Erwinaze and Vyxeos. Prior to Jazz, she was a member of the in-house legal team at Bristol Myers-Squibb supporting the company’s oncology, cardiovascular and virology franchises. In private practice, Allison represented numerous life sciences companies at Orrick, Herrington and Sutcliffe. Allison holds a J.D. from Columbia University School of Law and a B.A. from the University of Rochester.